Royalty rate due to regulatory approvals
Bristol-Myers Squibb·Geographic·2 segments
Breakdown
Segments
North AmericaView metric
Rest of World Except Japan, South Korea and TaiwanView metric
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Rest of World Except Japan, South Korea and Taiwan | 15% | 15% | 15% | 15% | 15% |
| North America | 4% | 4% | 4% | 4% | 4% |
| Total | 4% | 4% | 4% | 4% | 4% |
All segment values are derived from annual filings.